209 related articles for article (PubMed ID: 8604437)
1. Antischistosomal drugs: past, present ... and future?
Cioli D; Pica-Mattoccia L; Archer S
Pharmacol Ther; 1995; 68(1):35-85. PubMed ID: 8604437
[TBL] [Abstract][Full Text] [Related]
2. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
3. Schistosomiasis drug therapy and treatment considerations.
Shekhar KC
Drugs; 1991 Sep; 42(3):379-405. PubMed ID: 1720380
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
[TBL] [Abstract][Full Text] [Related]
5. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
Wang Y; Xu J; Xia C
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
7. Macromolecular bases of antischistosomal therapy.
Angelucci F; Miele AE; Boumis G; Brunori M; Dimastrogiovanni D; Bellelli A
Curr Top Med Chem; 2011; 11(16):2012-28. PubMed ID: 21619508
[TBL] [Abstract][Full Text] [Related]
8. New insight into praziquantel against various developmental stages of schistosomes.
Wu W; Wang W; Huang YX
Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
[TBL] [Abstract][Full Text] [Related]
9. Praziquantel, a new board-spectrum antischistosomal agent.
Gönnert R; Andrews P
Z Parasitenkd; 1977 Jul; 52(2):129-50. PubMed ID: 410178
[TBL] [Abstract][Full Text] [Related]
10. [Advances in research on antischistosomal drugs].
Qiu SJ; Xia CM
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive steroid concentrations in women with early active schistosomiasis: lack of effect of antischistosomal drugs.
el-Raghy I; Back DJ; Osman F; Orme ML; Fathalla M
Contraception; 1986 Apr; 33(4):373-7. PubMed ID: 3089682
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.
El Kouni MH
Comp Biochem Physiol B Biochem Mol Biol; 2017 Nov; 213():55-80. PubMed ID: 28735972
[TBL] [Abstract][Full Text] [Related]
14. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites.
Utzinger J; Xiao S; Keiser J; Chen M; Zheng J; Tanner M
Curr Med Chem; 2001 Dec; 8(15):1841-60. PubMed ID: 11772354
[TBL] [Abstract][Full Text] [Related]
15. Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads.
Panic G; Keiser J
Curr Opin Pharmacol; 2018 Oct; 42():27-33. PubMed ID: 30077117
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects.
Rennar GA; Gallinger TL; Mäder P; Lange-Grünweller K; Haeberlein S; Grünweller A; Grevelding CG; Schlitzer M
Eur J Med Chem; 2022 Nov; 242():114641. PubMed ID: 36027862
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing for schistosomiasis: molecular docking and dynamics investigations.
Ezebuo FC; Uzochukwu IC
J Biomol Struct Dyn; 2022 Feb; 40(3):995-1009. PubMed ID: 32924851
[TBL] [Abstract][Full Text] [Related]
18. Schistosomiasis therapeutics: whats in the pipeline?
Trainor-Moss S; Mutapi F
Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
[TBL] [Abstract][Full Text] [Related]
19. Modern approaches to accelerate discovery of new antischistosomal drugs.
Neves BJ; Muratov E; Machado RB; Andrade CH; Cravo PV
Expert Opin Drug Discov; 2016 Jun; 11(6):557-67. PubMed ID: 27073973
[TBL] [Abstract][Full Text] [Related]
20. Praziquantel derivatives with antischistosomal activity: aromatic ring modification.
Wang ZX; Chen JL; Qiao C
Chem Biol Drug Des; 2013 Aug; 82(2):216-25. PubMed ID: 23617439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
